4 quarters tracked · Beat rate 75% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $1.57 | $1.64 | +4.7% | Beat |
| Q2 2026 | 2025-12-31 | $1.45 | $1.39 | -4.0% | Miss |
| Q1 2026 | 2025-09-30 | $0.79 | $0.85 | +7.0% | Beat |
| Q4 2025 | 2025-06-30 | $2.23 | $2.87 | +28.7% | Beat |
Earnings Beat Rate
Clorox has beaten analyst EPS estimates in 3 of 4 tracked quarters (75% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →